Ultragenyx Pharmaceutical RARE Earnings Call Transcripts

NASDAQ RARE
$16.41 +0.98 (+6.35%)
At close: Nov 9, 2026 · 4:00 PM EST
11 earnings calls on file for Ultragenyx Pharmaceutical, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Ultragenyx Pharmaceutical Q3 2026 Earnings Call

Nov 3, 2026 8,749 words · 38 min read
  • Emil KakkisChief Executive Officer and President
  • Howard HornChief Financial Officer
  • Erik HarrisChief Commercial Officer
  • Eric CrombezChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Ultragenyx Pharmaceutical Earnings Call Transcripts

Calls11
LatestNov 3, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 11 Ultragenyx Pharmaceutical transcripts Register to get access to Ultragenyx Pharmaceutical’s earnings call transcripts.